login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Scientist Have Developed Novel Treatment For Genetic Diseases Including Cystic Fibrosis
By modifying the properties of the antibiotic gentamicin, commonly used to treat bacterial infections, the researchers claim to have developed a novel treatment for many human genetic diseases, including cystic fibrosis (CF), Duchenne muscular dystrophy, Usher Syndrome and numerous cancers.
Gentamicin belongs to a class of antibiotics called aminoglycosides.
The team led by Professor Timor Baasov of the Technion Faculty of Chemistry have modified existing aminoglycoside antibiotic drugs, and carefully monitored biological and toxicity tests of the resulting derivatives.
They came across "NB54," a new chemical derivative of gentamicin.
"We've created a new purpose for aminoglycosides by removing their traditional, natural actions as antibiotics," said Baasov.
"The loss of their antibacterial activity makes them highly selective, less toxic, and allows for their use in repairing 'wrong' genes in human beings," he added.
The findings were published in the Journal of Medicinal Chemistry.
Source-ANI
ARU
|
|
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
- News Quick Links
 |
Cystic Fibrosis
Complete Medindia Resources
|
| News Categories: |
| » | Report: A Lot of Americans Have No Access to Health Care |
| » | Greece Faces Humanitarian Crisis as Health Care Access Declines in EU, Doctors Group Warns |
| » | HCCI Report Says Rising Prices for Care Responsible for Increased Healthcare Costs for Privately Insured Americans |
| » | Treatment in ED is Based on Children's Insurance Status |
| » | US Spends Most on Healthcare Without Providing Superior Care |
| More Insurance News | |
|
